Surface Dependencies for a Shared Platform Renewal Before a Commercial Review

A shared platform renewal rarely belongs to one relationship. Research users decide whether the tool still solves a real problem, core operations tracks the support tickets and training records, procurement holds the timeline and the budget, and a commercial owner signs the final terms. As the strategic account manager, your job before the commercial review is not to defend the price. It is to find out what each group still needs to see before it can say yes, and to make sure those answers reach the right people early enough to matter.

Why This Conversation Goes Wrong

Most renewal conversations for a shared platform break down the same way. The account manager treats the review as one conversation about price, so questions from research and operations get folded into a generic status update. The account manager also tries to answer every evidence question personally, because it feels efficient in the moment, and ends up guessing at scientific value or promising records that never fully show up. Meanwhile procurement is running its own clock toward a renewal date, and nobody has confirmed who actually speaks for the labs. By the time the commercial review happens, the room is full of people who still disagree about basic facts, and the conversation about terms gets dragged back into an argument about whether the platform is even working. This is not a sign the deal is in trouble. It is a sign the dependencies were never surfaced out loud, and that is a preparation problem, not a pricing problem.

How to Prepare Before the Review

Before you schedule anything with procurement, map who owns each open question. Research users own whether the platform still fits their daily work. Core operations owns the service history, meaning support cases, uptime, and training completion. Procurement owns the renewal timeline and the budget contact. A commercial owner, whether that is you or someone above you, owns the actual terms. Write this down as a short dependency list with four parts for each item, the review topic, the source of the answer, the person who owns confirming it, and a due date.

1. Platform fit for daily lab work, owned by the research lead, feedback due before the review.
2. Support case history and training completion, owned by core operations, records due one week ahead.
3. Renewal timeline and budget approval, owned by procurement, confirmed the same week.
4. Contract terms, owned by the commercial owner, drafted only after the first three items are settled.

Confirming who actually receives and reviews each piece of information, rather than assuming it lands with the right person, matters as much here as it does in logistics. The same discipline shows up in Confirm Receiving Contacts Before Requesting a Split Shipmentwhere naming the receiving contact before you split a shipment prevents the same kind of stall. And if part of your evidence has to come from a live site rather than a support system, Plan a Laboratory Site Tour Around Evaluation Evidence covers building that evidence trail before stakeholders arrive.

What to Say

Luis, a core director you have worked with for two years, opens the conversation the way most of these stall. He says, "Procurement wants an answer, but the labs are still arguing about whether this thing earns its budget line."

That is the moment to ask an evidence question before anything about price comes up. You say, "What would your team need to see to decide whether this stays useful? And who can tell me the actual timeline procurement is working against?"

Luis thinks about it and says, "Give me support case history for the last two quarters, completion rates from the training sessions, and whatever user feedback you have on file. If the labs see the same numbers, they will stop arguing past each other."

You confirm, "I will pull the support history from the service team and route the feedback request straight to whichever reviewers the labs choose. Who on procurement can confirm the renewal date and the budget contact?"

Luis says, "Ask for Dana. She owns the timeline, and she will tell you what number they are planning around."

That exchange does three things. It puts the evidence question ahead of the price question. It names an owner for every piece of information instead of letting you become the source. And it gets a real name and timeline from procurement instead of an assumption you would otherwise have carried into the review.

Mistakes to Avoid

A few habits sink this conversation even when your intentions are good.

1. Do not answer the evidence question yourself. If you tell Luis the platform is working well based on your own read of the support tickets, you have replaced the labs' judgment with yours, and that will not hold up once the labs compare notes.
2. Do not turn activity records into a claim about scientific outcomes. Ticket counts and training completion tell you how the platform gets used. They do not tell you whether an experiment succeeded because of it. State what the data shows and stop there.
3. Do not skip the due dates. A dependency list without dates is just a list of hopes. Attach a date to each item and follow up on that date, not after the review has already started.
4. Do not let procurement set the pace for the whole renewal. Procurement's clock is real, but if research feedback is not ready, say so plainly and ask for a short extension rather than forcing a review that will only restart the argument.
5. Do not assume silence from a stakeholder means agreement. If the research lead has not sent feedback, that is an open dependency, not a resolved one, and it should stay on the list until it closes.

How to Practice and Score It

This conversation is worth rehearsing before you have it for real, because the failure mode, jumping straight to terms, is easy to fall into under time pressure. A manager can run this as a short roleplay, playing Luis or the procurement contact, and score you on three things. Did you ask an evidence question before a price question. Did you name a specific owner for each piece of information instead of promising to handle it all yourself. Did you get an actual date or name out of the other person instead of a vague commitment.

DealSpeak is built for this kind of rehearsal. You can run the same conversation against an AI counterpart playing the core director or the procurement contact, get a transcript afterward, and see exactly where you drifted into answering questions that belonged to someone else. Practicing it once with real feedback is worth more than reading the dependency list a second time.

Where This Leaves You

A shared platform renewal is really several smaller conversations that have to land in the right order. Surface the dependencies early, route each question to the person who can actually answer it, and the commercial review becomes a formality instead of a fight. For more scenarios built around this kind of coordination, look at Biotechnology practice conversations.